{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:46:07Z","timestamp":1791953167975,"version":"4.3.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82570781"],"award-info":[{"award-number":["82570781"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hepatobiliary & Pancreatic Diseases International"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.hbpd.2026.09.006","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:19:44Z","timestamp":1791040784000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CPT1A-driven metabolic reprogramming serves as a compensatory adaptation to sustain energy homeostasis in obstructive cholestasis"],"prefix":"10.1016","author":[{"given":"Zhong-Shan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Fa","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Jun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hbpd.2026.09.006_bib0001","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s40265-021-01545-7","article-title":"Cholestatic liver disease: current treatment strategies and new therapeutic agents","volume":"81","author":"Hasegawa","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0002","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000179","article-title":"Primary biliary cholangitis: epidemiology, prognosis, and treatment","volume":"7","author":"Trivella","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0003","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.6004\/jnccn.2010.0075","article-title":"Malignant biliary tract obstruction: evaluation and therapy","volume":"8","author":"Chu","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0004","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13737","article-title":"Changes in protein metabolism and early development of sarcopenia in mice with cholestatic liver disease","volume":"16","author":"Agrifoglio","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0005","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/hep.29003","article-title":"A practical approach to nutritional screening and assessment in cirrhosis","volume":"65","author":"Tandon","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0006","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jhep.2018.06.024","article-title":"EASL Clinical Practice Guidelines on nutrition in chronic liver disease","volume":"70","author":"Merli","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0007","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.clnu.2024.11.028","article-title":"Medium-chain triglyceride supplementation and the association with growth, nutritional status and clinical outcomes in infants with biliary atresia","volume":"44","author":"Mancell","year":"2025","journal-title":"Clin Nutr"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0008","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1074\/jbc.RA120.013700","article-title":"Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator-activated receptor \u03b1","volume":"295","author":"Gordon","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0009","doi-asserted-by":"crossref","first-page":"G668","DOI":"10.1152\/ajpgi.00026.2018","article-title":"Biliverdin reductase and bilirubin in hepatic disease","volume":"314","author":"Weaver","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.586715","article-title":"Mitochondrial function, fatty acid metabolism, and body composition in the hyperbilirubinemic gunn rat","volume":"12","author":"Vidimce","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0011","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3390\/antiox11091742","article-title":"Induction of BVR-a expression by Korean red ginseng in murine hippocampal astrocytes: role of bilirubin in mitochondrial function via the LKB1\u2013SIRT1\u2013ERR\u03b1 axis","volume":"11","author":"Moon","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102643","article-title":"Mitochondrial cholesterol: metabolism and impact on redox biology and disease","volume":"61","author":"Goicoechea","year":"2023","journal-title":"Redox Biol"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0013","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.freeradbiomed.2024.05.042","article-title":"Forsythiaside-a improved bile-duct-ligation-induced liver fibrosis in mice: the involvement of alleviating mitochondrial damage and ferroptosis in hepatocytes via activating Nrf2","volume":"222","author":"Guo","year":"2024","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0014","first-page":"5","article-title":"Recent advances in the development of farnesoid X receptor agonists","volume":"3","author":"Ali","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0015","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/gutjnl-2022-326987","article-title":"FOXA2 prevents hyperbilirubinaemia in acute liver failure by maintaining apical MRP2 expression","volume":"72","author":"Wang","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0016","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3390\/cells10081846","article-title":"Farnesoid X receptor as target for therapies to treat cholestasis-induced liver injury","volume":"10","author":"Petrescu","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0017","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0168-8278(99)80069-5","article-title":"The liver carnitine pool reflects alterations in hepatic fatty acid metabolism in rats with bile duct ligation before and after biliodigestive anastomosis","volume":"30","author":"W\u00e4chter","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0018","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1911534","article-title":"Intestinal microbiota drives cholestasis-induced specific hepatic gene expression patterns","volume":"13","author":"Juanola","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0019","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.1152\/ajpendo.00405.2020","article-title":"Bilirubin as a metabolic hormone: the physiological relevance of low levels","volume":"320","author":"Creeden","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1053\/j.gastro.2024.05.014","article-title":"Gut microbiota-derived butyrate induces epigenetic and metabolic reprogramming in myeloid-derived suppressor cells to alleviate primary biliary cholangitis","volume":"167","author":"Wang","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217006","article-title":"CPT1A loss disrupts BCAA metabolism to confer therapeutic vulnerability in TP53-mutated liver cancer","volume":"595","author":"Liu","year":"2024","journal-title":"Cancer Lett"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0022","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1055\/s-0042-1747933","article-title":"Prolonged cholestatic jaundice associated with carnitine palmitoyltransferase IA deficiency","volume":"13","author":"Mirza","year":"2024","journal-title":"J Pediatr Genet"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155285","article-title":"Formononetin promotes fatty acid \u03b2-oxidation to treat non-alcoholic steatohepatitis through SIRT1\/PGC-1\u03b1\/PPAR\u03b1 pathway","volume":"124","author":"Liao","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0024","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqz046","article-title":"CPT1A-mediated fat oxidation, mechanisms, and therapeutic potential","volume":"161","author":"Schlaepfer","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0025","article-title":"Mild hypothermia attenuates hepatic ischemia-reperfusion injury by regulating FoxO1\/PPAR\u03b1 pathway","volume":"15","author":"Lu","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0026","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1042\/CS20230812","article-title":"Gut microbiota depletion aggravates bile acid-induced liver pathology in mice with a human-like bile acid composition","volume":"137","author":"Verkade","year":"2023","journal-title":"Clin Sci"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0027","article-title":"Hepatic sarcoidosis resembling primary sclerosing cholangitis","volume":"15","author":"Chen","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0028","article-title":"Transport mechanism of human bilirubin transporter ABCC2 tuned by the inter-module regulatory domain","volume":"3","author":"Mao","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0029","first-page":"60","article-title":"Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury","volume":"316","author":"Iruzubieta","year":"2019","journal-title":"JHEP Rep"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0030","first-page":"60","article-title":"Cholestasis-associated reproductive toxicity in male and female rats: the fundamental role of mitochondrial impairment and oxidative stress","volume":"13","author":"Ommati","year":"2021","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0031","first-page":"S116","article-title":"ABCB10 exports mitochondrial biliverdin, driving metabolic maladaptation in obesity","volume":"59","author":"Shum","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0032","first-page":"S116","article-title":"N-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: a critical review","volume":"115","author":"Wang","year":"2018","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0033","first-page":"1193","article-title":"Chemoproteomics reveals baicalin activates hepatic CPT1 to ameliorate diet-induced obesity and hepatic steatosis","volume":"127","author":"Dai","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0034","first-page":"9804","article-title":"Nutrient-sensing nuclear receptors PPAR\u03b1 and FXR control liver energy balance","volume":"295","author":"Preidis","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0035","first-page":"1335","article-title":"Bilirubin as a signaling molecule","volume":"16","author":"V\u00edtek","year":"2025","journal-title":"Med Res Rev"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0036","first-page":"1317","article-title":"Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator\u2013activated receptor \u03b1","volume":"79","author":"Gordon","year":"2023","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0037","article-title":"Changes in protein metabolism and early development of sarcopenia in mice with cholestatic liver disease","volume":"11","author":"Agrifoglio","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0038","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.jhep.2023.07.034","article-title":"FXR agonists in NASH treatment","volume":"79","author":"Adorini","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.hbpd.2026.09.006_bib0039","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s40168-023-01709-5","article-title":"Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia","volume":"11","author":"Xu","year":"2023","journal-title":"Microbiome"}],"container-title":["Hepatobiliary & Pancreatic Diseases International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387226001591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1499387226001591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T04:04:04Z","timestamp":1791950644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1499387226001591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"alternative-id":["S1499387226001591"],"URL":"https:\/\/doi.org\/10.1016\/j.hbpd.2026.09.006","relation":{},"ISSN":["1499-3872"],"issn-type":[{"value":"1499-3872","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CPT1A-driven metabolic reprogramming serves as a compensatory adaptation to sustain energy homeostasis in obstructive cholestasis","name":"articletitle","label":"Article Title"},{"value":"Hepatobiliary & Pancreatic Diseases International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hbpd.2026.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}